AU2001281465A1 - Treatment of rosacea - Google Patents

Treatment of rosacea

Info

Publication number
AU2001281465A1
AU2001281465A1 AU2001281465A AU8146501A AU2001281465A1 AU 2001281465 A1 AU2001281465 A1 AU 2001281465A1 AU 2001281465 A AU2001281465 A AU 2001281465A AU 8146501 A AU8146501 A AU 8146501A AU 2001281465 A1 AU2001281465 A1 AU 2001281465A1
Authority
AU
Australia
Prior art keywords
rosacea
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001281465A
Inventor
Michael T. Kelly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seatek Marine Biotechnology Inc
Original Assignee
Seatek Marine Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seatek Marine Biotechnology Inc filed Critical Seatek Marine Biotechnology Inc
Publication of AU2001281465A1 publication Critical patent/AU2001281465A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41681,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/45Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2001281465A 2000-03-17 2001-03-19 Treatment of rosacea Abandoned AU2001281465A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2301336 2000-03-17
CA002301336A CA2301336A1 (en) 2000-03-17 2000-03-17 Topical treatment of rosacea
PCT/CA2001/000358 WO2001068675A2 (en) 2000-03-17 2001-03-19 Treatment of rosacea

Publications (1)

Publication Number Publication Date
AU2001281465A1 true AU2001281465A1 (en) 2001-09-24

Family

ID=4165558

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001281465A Abandoned AU2001281465A1 (en) 2000-03-17 2001-03-19 Treatment of rosacea

Country Status (4)

Country Link
US (1) US7153826B2 (en)
AU (1) AU2001281465A1 (en)
CA (1) CA2301336A1 (en)
WO (1) WO2001068675A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2408263A (en) * 2003-11-14 2005-05-25 Pacgen Biopharmaceuticals Inc Antimicrobial peptides with reduced hemolysis and methods of their use.
US20060093675A1 (en) * 2004-10-29 2006-05-04 Mathew Ebmeier Intravaginal treatment of vaginal infections with metronidazole compositions
CN101906138B (en) * 2010-07-13 2012-10-17 暨南大学 A kind of pseudocyclic polypeptide and its synthesis method and application
CN101906149B (en) * 2010-07-13 2012-10-17 暨南大学 A kind of linear polypeptide and its synthesis method and application

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2128617A (en) * 1982-10-06 1984-05-02 Martti Vaara Polypeptides for use in antibacterial therapy
US5998200A (en) * 1985-06-14 1999-12-07 Duke University Anti-fouling methods using enzyme coatings
DE4328871A1 (en) 1993-08-27 1995-03-02 Beiersdorf Ag Means against sensitive, hyper-reactive skin conditions, atopic dermatitis, pruritus, psoriasis prurigo, photodermatoses and ichthyosis
US5587358A (en) * 1994-05-09 1996-12-24 Asahi Kasei Kogyo Kabushiki Kaisha Potentiators of antimicrobial activity
FR2732221B1 (en) * 1995-03-28 1997-04-25 Oreal USE OF A CGRP ANTAGONIST TO TREAT CUTANEOUS REDNESS OF NEUROGENIC ORIGIN AND COMPOSITION OBTAINED
WO1998004584A1 (en) * 1996-07-26 1998-02-05 Seatek Marine Biotechnology, Inc. Cyclic decapeptide antibiotics
MXPA02006029A (en) * 1999-12-15 2004-08-23 Cubist Pharm Inc Novel lipopeptides as antibacterial agents.
CA2394313A1 (en) * 1999-12-15 2001-06-21 Cubist Pharmaceuticals, Inc. Novel lipopeptides as antibacterial agents
US6696412B1 (en) * 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same

Also Published As

Publication number Publication date
US7153826B2 (en) 2006-12-26
WO2001068675A2 (en) 2001-09-20
WO2001068675A3 (en) 2001-12-13
US20040023857A1 (en) 2004-02-05
CA2301336A1 (en) 2001-09-17

Similar Documents

Publication Publication Date Title
AU2002223827A1 (en) Well treatment
AU2002257936A1 (en) Methods of well treatment
AUPR406501A0 (en) Treatment of vault prolapse
AU2002215125A1 (en) Well treatment method
AU2001286983A1 (en) Method of treatment
AU2001247841A1 (en) Medical procedure
AU2002231206A1 (en) Treatment of depression
AU2002319286A1 (en) Skin treatment
AUPR731901A0 (en) Method of treatment
AU2001257325A1 (en) Cancer treatment
AU2001245414A1 (en) Treatment of allergies
AU2002335667A1 (en) Modified reoviral therapy
AU2001281465A1 (en) Treatment of rosacea
AU1618901A (en) Treatment of rosacea
AU2001262177A1 (en) Method of treatment
AU2001253560A1 (en) Methods of treatment
AU2001289127A1 (en) Tumor treatment
AU2001257168A1 (en) Cancer treatment
AUPR814901A0 (en) Water treatment
HK1056502A (en) Methods of treatment
AU2001250000A1 (en) Treatment of vitiligo
AU2002226380A1 (en) Tissue treatment
AUPR213000A0 (en) Method of treatment
AUPQ662500A0 (en) Method of treatment
AUPQ949500A0 (en) Method of treatment